The future of hormone replacement therapy in the aging male

Aging Male

Volumn 3, Issue 4, 2000, Pages 210-213

  Vermeulen, A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aging male; Hormone replacement therapy

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; CLINICAL FEATURE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK BENEFIT ANALYSIS; TESTOSTERONE BLOOD LEVEL; TREATMENT INDICATION;

EID: 0034503470     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/13685530008500348     Document Type: Review

References (11)

1. Transport of protein-bound hormones into tissues in vivo
2. Androgens in male senescence
3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging and obese males
4. The gonadotropin suppressive activity is increased in aging men
5. Influence of age on pulsatile luteinising hormone release and responsiveness of the gonadotrophs to sex hormone feedback
6. Androgen receptors in rat brain, anterior pituitary gland and ventral prostate gland: Effect of orchiectomy and aging
7. Hormones and human sexual behavior
8. Effect of testosterone replacement therapy in old hypogonadal males: A preliminary study
9. Effects of testosterone supplementation in the ageing male
10. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls
11. Selective androgen receptor modulators (SARMs): A novel approach to androgen therapy in the new millennium